Phosphoproteomics

被引:21
作者
Stern, DF [1 ]
机构
[1] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA
关键词
D O I
10.1006/exmp.2001.2370
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
[No abstract available]
引用
收藏
页码:327 / 331
页数:5
相关论文
共 10 条
[1]   Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling [J].
Alizadeh, AA ;
Eisen, MB ;
Davis, RE ;
Ma, C ;
Lossos, IS ;
Rosenwald, A ;
Boldrick, JG ;
Sabet, H ;
Tran, T ;
Yu, X ;
Powell, JI ;
Yang, LM ;
Marti, GE ;
Moore, T ;
Hudson, J ;
Lu, LS ;
Lewis, DB ;
Tibshirani, R ;
Sherlock, G ;
Chan, WC ;
Greiner, TC ;
Weisenburger, DD ;
Armitage, JO ;
Warnke, R ;
Levy, R ;
Wilson, W ;
Grever, MR ;
Byrd, JC ;
Botstein, D ;
Brown, PO ;
Staudt, LM .
NATURE, 2000, 403 (6769) :503-511
[2]   ANTISERUM RAISED AGAINST A SYNTHETIC PHOSPHOTYROSINE-CONTAINING PEPTIDE SELECTIVELY RECOGNIZES P185(NEU/ERBB-2) AND THE EPIDERMAL GROWTH-FACTOR RECEPTOR [J].
BANGALORE, L ;
TANNER, AJ ;
LAUDANO, AP ;
STERN, DF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (23) :11637-11641
[3]   Genomic analysis of metastasis reveals an essential role for RhoC [J].
Clark, EA ;
Golub, TR ;
Lander, ES ;
Hynes, RO .
NATURE, 2000, 406 (6795) :532-535
[4]  
DIGIOVANNA MP, 1995, CANCER RES, V55, P1946
[5]   Functional assay for HER-2/neu demonstrates active signalling in a minority of HER-2/neu-overexpressing invasive human breast tumours [J].
DiGiovanna, MP ;
Carter, D ;
Flynn, SD ;
Stern, DF .
BRITISH JOURNAL OF CANCER, 1996, 74 (05) :802-806
[6]   SYNTHETIC PHOSPHOPEPTIDE IMMUNOGENS YIELD ACTIVATION-SPECIFIC ANTIBODIES TO THE C-ERBB-2 RECEPTOR [J].
EPSTEIN, RJ ;
DRUKER, BJ ;
ROBERTS, TM ;
STILES, CD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (21) :10435-10439
[7]  
Gioeli D, 1999, CANCER RES, V59, P279
[8]   The hallmarks of cancer [J].
Hanahan, D ;
Weinberg, RA .
CELL, 2000, 100 (01) :57-70
[9]   THE BIOLOGY OF ERBB-2 NEU HER-2 AND ITS ROLE IN CANCER [J].
HYNES, NE ;
STERN, DF .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1994, 1198 (2-3) :165-184
[10]   Activation (tyrosine phosphorylation) of ErbB-2 (HER-2/neu):: A study of incidence and correlation with outcome in breast cancer [J].
Thor, AD ;
Liu, S ;
Edgerton, S ;
Moore, D ;
Kasowitz, KM ;
Benz, CC ;
Stern, DF ;
DiGiovanna, MP .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (18) :3230-3239